These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Grabowski J; Douyon R; Thomas J; Henderson W; Charney D Health Serv Res; 1998 Dec; 33(5 Pt 1):1237-61. PubMed ID: 9865219 [TBL] [Abstract][Full Text] [Related]
8. Pharmacoeconomic evaluation of treatments for refractory schizophrenia: clozapine-related studies. Revicki DA J Clin Psychiatry; 1999; 60 Suppl 1():7-11; discussion 28-30. PubMed ID: 10037164 [TBL] [Abstract][Full Text] [Related]
9. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240 [TBL] [Abstract][Full Text] [Related]
10. Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel. Ginsberg G; Shani S; Lev B Pharmacoeconomics; 1998 Feb; 13(2):231-41. PubMed ID: 10178649 [TBL] [Abstract][Full Text] [Related]
11. The Business Case for Expanded Clozapine Utilization. Gören JL; Rose AJ; Smith EG; Ney JP Psychiatr Serv; 2016 Nov; 67(11):1197-1205. PubMed ID: 27301766 [TBL] [Abstract][Full Text] [Related]
12. Clozapine: current status and role in the pharmacotherapy of schizophrenia. Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645 [TBL] [Abstract][Full Text] [Related]
13. Clozapine's cost effectiveness. Schiller M; Hargreaves WA Am J Psychiatry; 1995 Jan; 152(1):151-2; author reply 153-4. PubMed ID: 7802112 [No Abstract] [Full Text] [Related]
18. Pharmacoeconomic evaluation of clozapine in treatment-resistant schizophrenia: a cost-utility analysis. Oh PI; Iskedjian M; Addis A; Lanctôt K; Einarson TR Can J Clin Pharmacol; 2001; 8(4):199-206. PubMed ID: 11743592 [TBL] [Abstract][Full Text] [Related]
19. [Medico-economic study of Léponex (clozapine) in the Bordeaux Charles Perrens Hospital Center]. Bret P; Jolivel C; Bret MC; Veylit S; Martin C; Garcia P Encephale; 1998; 24(4):365-77. PubMed ID: 9809242 [TBL] [Abstract][Full Text] [Related]